Skip to content

The study of the effect of Cobb's angle on according to apply to ALL LINE ™ during 12 weeks in scoliosis patients

A single institution, open-label study, and trial-and-error study for verifying the effect of Cobb's angle on 12-week ALL LINE ™ splint wearing scoliosis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0004097
Enrollment
20
Registered
2019-06-27
Start date
2017-07-24
Completion date
Unknown
Last updated
2019-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Interventional medical devices Medical device items: Class 1 splint Wear time: 12 hours / day Wear period: 12 weeks Wearing type: Two sets consist of upper and lower belt

Sponsors

Chonbuk National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Man and woman aged 19 and over, 40 and under 2) A person who was diagnosed with scoliosis by X-ray (Cobb's angle between 10 and 40 degrees) 3) A person who can perform simple radiography and agrees 4) Those who have voluntarily given written consent to the clinical trial

Exclusion criteria

Exclusion criteria: 1) Those with progressive neurological deficits or with severe neurological symptoms 2) Those with structural deformations and imbalances in the spine, pelvis, and lower limb skeleton. 3) The difference between the left and right deviation of the pelvis is 1cm or more. 4) Those who are judged to be difficult to participate under the judgment of the research supervisor

Design outcomes

Primary

MeasureTime frame
Cobb's Angle Change Measurement

Secondary

MeasureTime frame
Measurement of body height change

Countries

Korea, Republic of

Contacts

Public ContactSEUNGROK KANG

Chonbuk National University Hospital

srkang@mdctc.or.kr+82-63-259-3458

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026